ARMGO Pharma, Inc. Alternatives & Competitors

12 companies similar to ARMGO Pharma, Inc. — First-in-Class Disease-Modifying Therapeutics in Cardiac and Skeletal Muscle Dis...

Reservoir Neuroscience

Developing the world's first therapeutics to heal broken blood vessels in the brain

3 Venture round $7.86M

Emeryville, United States

Biopharma Biotechnology +1

Nanna Therapeutics

Disease-modifying Medicines

20 Grant $829.89K

Cambridge, United Kingdom

AI Biotechnology +2

Abarceo Pharma AB

Developing the first disease modifying and durable treatment for type 2 and type 1 diabete...

9 Venture round $21.50M

Malmo, Sweden

Biotechnology Health and Wellness +1

Spinogenix, Inc.

Developing a new class of therapeutics for neurodegenerative and psychiatric diseases

4 $8.36M

Los Angeles, United State...

Biotechnology Health Care +1

Track all ARMGO Pharma, Inc. competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Biomea Fusion

We are creating an entirely new Generation of Precision Medicine against Genetically Defin...

99 Post-IPO Equity $206.00M

United States

Biotechnology Health and Wellness +1

Illimis Therapeutics

18 Venture round

Seoul, Korea South

Biopharma Biotechnology +3

Rigel Pharmaceuticals Inc.

A biotechnology company dedicated to providing small molecule drugs that significantly imp...

272 Grant

South San Francisco, Unit...

Biotechnology Health Care +2

Morphic Therapeutic

Wholly owned subsidiary of Eli Lilly and Company

128 Post-IPO Equity

Waltham, United States

Biotechnology Health Care +1

Cellzome

36 Grant $65.95M

Biotechnology Health and Wellness +1

ConoGenetix biosciences

Pioneering peptide therapeutics to combat autoimmune diseases.

Series A $1.50M

Biopharma Biotechnology +2

Ashvattha Therapeutics, Inc.

Harnessing the power of hydroxyl dendrimers to create a new class of disease cell-targeted...

24 Series B $148.04M

Redwood City, United Stat...

Biotechnology Health Care +2

ImmunoBiochem Corporation

Improving patient outcomes through innovations in biological therapeutics

4 Seed

Toronto, Canada

Biotechnology Health Care +1

About ARMGO Pharma, Inc.

ARMGO Pharma, Inc. is a biopharmaceutical company that has been developing targeted small-molecule therapeutics to combat severe cardiac, skeletal muscular, and neurological disorders since 2004. The company's flagship products, rycals, act as calcium release channel stabilizers targeting the ryanodine receptor/calcium...

Business keywords

Biopharmaceutical, Therapeutics, Small-molecule, Cardiac Disorders, Muscular Disorders, Neurological Disorders, Rycals, Calcium Release Channel Stabilizers, Ryanodine Receptor, Chronic Heart Failure, Cardiac Arrhythmias, Malignant Hyperthermia, Diabetes, Chronic Obstructive Pulmonary Disease, High Blood Pressure

Frequently Asked Questions

Companies similar to ARMGO Pharma, Inc. include Reservoir Neuroscience, Nanna Therapeutics, Abarceo Pharma AB, Spinogenix, Inc., Biomea Fusion. They work in Biotechnology and Health and Wellness and share ARMGO Pharma, Inc.'s focus on therapeutics, neurological disorders and biopharmaceutical.

Bounce Watch lists 12 companies that share ARMGO Pharma, Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches ARMGO Pharma, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

ARMGO Pharma, Inc. Profile Reservoir Neuroscience Alternatives Nanna Therapeutics Alternatives Abarceo Pharma AB Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at ARMGO Pharma, Inc. on 12 Sep 2024. The 10 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.